SanBio : Notice Concerning Difference Between Consolidated Financial Forecasts and Actual Results for the First Half of the Fiscal Year Ending January 31 2022

	September 14, 2021
Company name:	SanBio Co., Ltd.
Representative:	Keita Mori, Representative Director and
	President
	(TSE Mothers Code: 4592)
Contact:	Yoshihiro Kakutani, Corporate Officer of
	Management Administration
	(TEL. [phone])

Notice Concerning Difference Between Consolidated Financial Forecasts and Actual Results

for the First Half of the Fiscal Year Ending January 31, 2022

SanBio Company Limited (hereafter, "the Company") hereby announces the difference between consolidated financial forecasts disclosed on March 17, 2021 and the actual results disclosed today, for the first half of the fiscal year ending January 31, 2022 (from February 1, 2021 to July 31, 2021).

1. Difference between consolidated forecasts and actual results for the first half of the fiscal year ending January 31, 2022 (from February 1, 2021 to July 31, 2021)

				Net Income
	Operating	Operating	Ordinary	Attributable to	Net Income
	Revenue	Income	Income	Owners of	Per Share
				Parent
Previous Forecast (A)	Million yen	Million yen	Million yen	Million yen	Yen
(as of March 17, 2021)	－	-3,492	-3,550	-3,551	-68.57
Actual Results (B)	－	-3,052	-2,146	-2,134	-41.21
Difference (B-A)	－	440	1,404	1,417
Percentage Change (%)	－	－	－	－
(Reference) Actual results
for the six months ended	－	-2,570	-3,205	-3,207	-61.94
July 31, 2020)

2. Reasons for the difference

The operating loss was as noted above, as R&D and manufacturing expenses expected to be recognized in the first half of the fiscal year now will be booked in the second half. The ordinary loss and net loss attributable to owners of parent were as noted above, as the Company booked a foreign exchange gain due to the depreciation of the yen.

Consolidated forecasts for the full year ending January 31, 2022 are unchanged from those released on March 17, 2021.